Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Kamran Ghoreschi, Anna Balato, Charlotta Enerbäck, et al.
The Lancet (2021) Vol. 397, Iss. 10275, pp. 754-766
Closed Access | Times Cited: 394

Showing 1-25 of 394 citing articles:

The Role of Helper T Cells in Psoriasis
Peng Hu, Mengyao Wang, Hu Gao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 139
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 116
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 112
Exploring the Links between Obesity and Psoriasis: A Comprehensive Review
Ana Gabriela Barros Peláez, Pablo Durán, Ivana Vera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7499-7499
Open Access | Times Cited: 71
Disease modification in inflammatory skin disorders: opportunities and challenges
Thomas Bieber
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 662-680
Closed Access | Times Cited: 43
Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1
Xiangyu Lu, Le Kuai, Fang Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Plant exosomes fused with engineered mesenchymal stem cell‐derived nanovesicles for synergistic therapy of autoimmune skin disorders
Rufan Huang, Bo Jia, Dandan Su, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 10
Open Access | Times Cited: 41
Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES
Rui Ma, Lian Cui, Jiangluyi Cai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 30
Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade
Luc Francis, Daniel McCluskey, Clarisse Gânier, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets
Lisha Li, Jiaye Lu, Jun Liu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 15
Association between systemic immune-inflammation index and psoriasis: a population-based study
Xiya Zhao, Junqin Li, Xinhua Li
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Hidradenitis suppurativa
Robert Sabat, Afsáneh Alavi, Kerstin Wolk, et al.
The Lancet (2025)
Open Access | Times Cited: 2
The role of interleukin-17 in inflammation-related cancers
Xingru Zhang, Bin Li, Lü Tian, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics
Hakim Ben Abdallah, Claus Johansen, Lars Iversen
Psoriasis Targets and Therapy (2021) Vol. Volume 11, pp. 83-97
Open Access | Times Cited: 57
Organizing structural principles of the IL-17 ligand–receptor axis
Steven C. Wilson, Nathanael A. Caveney, Michelle Yen, et al.
Nature (2022) Vol. 609, Iss. 7927, pp. 622-629
Open Access | Times Cited: 40
Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment
Tamás G. Gergely, Dániel Kucsera, Viktória É. Tóth, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 6, pp. 740-761
Open Access | Times Cited: 39
Inflammation and Psoriasis: A Comprehensive Review
Alessandra-Mădălina Man, Meda Sandra Orăsan, Oana-Alina Hoteiuc, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16095-16095
Open Access | Times Cited: 33
Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study
Matteo Megna, Angelo Ruggiero, Teresa Battista, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3233-3233
Open Access | Times Cited: 30
Interleukin‐21 in autoimmune and inflammatory skin diseases
Alberto Mesas‐Fernández, Euna Bodner, Franz J. Hilke, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 4
Open Access | Times Cited: 29
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation
Angelo Ruggiero, Luca Potestio, Fabrizio Martora, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 5, pp. 355-362
Closed Access | Times Cited: 29
Supramolecular Dissolving Microneedle Patch Loading Hydrophobic Glucocorticoid for Effective Psoriasis Treatment
Hua Wang, Yangxue Fu, Pei Liu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 12, pp. 15162-15171
Closed Access | Times Cited: 28
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
James G. Krueger, John W. Frew, Gregor B. E. Jemec, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 2, pp. 149-162
Open Access | Times Cited: 28
The Role of Adipokines in the Pathogenesis of Psoriasis
Kajetan Kiełbowski, Estera Bakinowska, Piotr Ostrowski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6390-6390
Open Access | Times Cited: 25
Centella asiatica alleviates psoriasis through JAK/STAT3-mediated inflammation: An in vitro and in vivo study
Pei Lin, Hongyu Shi, Yinying Lu, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116746-116746
Closed Access | Times Cited: 25
Current developments and perspectives in psoriasis
Michael P. Schön, Dagmar Wilsmann‐Theis
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 4, pp. 363-372
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top